Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omega-3 and risperidone in children with ADHD and refractory epilepsy
IRCT201604212639N18Phase 3Completed
- Sponsor
- Shahid Sadoughi University of Medical Sciences
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of omega-3 fatty acid and risperidone in epilepsy and attention deficit hyperactivity disorder (ADHD), sponsored by Shahid Sadoughi University of Medical Sciences. Started Jun 2015; status: completed.
02
Drugs
omega-3 fatty acidrisperidone
03
Conditions
epilepsyattention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on IRCT201604212639N18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201604212639N18.